Wikidata

(Q62818294)

English

The hyper-CVAD–rituximab chemotherapy programme followed by high-dose busulfan, melphalan and autologous stem cell transplantation produces excellent event-free survival in patients with previously untreated mantle cell lymphoma

scientific article published on 07 November 2006

In more languages

Statements

title
The hyper-CVAD-rituximab chemotherapy programme followed by high-dose busulfan, melphalan and autologous stem cell transplantation produces excellent event-free survival in patients with previously untreated mantle cell lymphoma (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
17089127
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17089127%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 December 2019
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q62818294&oldid=1752414930"